REXIS BIOTECH ANNOUNCES THE OFFICAL APPROVAL AND LAUNCH OF IT’S FUSED POLYMPORPH NANO FIBER TECHNOLOGY
Dover, Delaware – March 16, 2023 – Rexis Biotech Inc. (“REXIS”) is delighted to announce that, after more than three years of development and clinical trials, its innovative co-crystal formation and drug delivery platform, Fused Polymorph Nano Fiber TM, has received approval for use and distribution in the United States. Fused Polymorph Nano Fiber TM […]
